Publications by authors named "B Desablens"

Claim this Profile
R
Results of a Prospective Study of High-Dose or Conventional Anthracycline-Cyclophosphamide Regimen Plus Radiotherapy for Localized Adult Non-Hodgkin's Primary Bone Lymphoma.
A Schmidt-Tanguy, R Houot, S Lissandre, J F Abgrall, P Casassus, B Desablens

Adv Hematol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intermediate stage Hodgkin lymphoma in partial remission after three or four courses of doxorubicin, bleomycin, vinblastine dacarbazine: no benefit of one course of intensive chemotherapy before irradiation.
Nina Arakelyan, Jean-Philippe Jais, Cécile Tomowiack, Philippe Colombat, Christian Berthou, Bernard Desablens

Leuk Lymphoma· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95.
Audrey Simon, Michel Peoch, Philippe Casassus, Eric Deconinck, Philippe Colombat, Bernard Desablens

Br J Haematol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced versus full doses of irradiation after 3 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine in early stage Hodgkin lymphomas: results of a randomized trial.
Nina Arakelyan, Jean-Philippe Jais, Vincent Delwail, Josette Brière, Marie-Pierre Moles-Moreau, Bernard Desablens

Cancer· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation: five-year results of a randomized trial on behalf of the GOELAMS Group.
Nina Arakelyan, Christian Berthou, Bernard Desablens, Sophie de Guibert, Vincent Delwail

Cancer· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis